Leading Bio-Medical Company Adds Prominent Emergency Medicine Physician and
Seasoned Quality Assurance Executive to Team
SAN DIEGO, June 27 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated
(Nasdaq: BSTE) today announced Norman Paradis, M.D., has been named vice
president medical affairs and S. Elaine Walton has been promoted to vice
president, quality assurance and program management. Dr. Paradis will provide
medical guidance for clinical trial design, regulatory submissions, new
product prioritization, medical education, and product strategy and
positioning. Walton, who has more than 20 years of healthcare industry
experience, is responsible for quality assurance, compliance, quality system
training, operational audits and program management.
"With the expansion of our business, it is important for us to broaden
expertise within our management team," said Kim Blickenstaff, Biosite chairman
and chief executive officer. "Both Norm and Elaine possess experience and
skills that will contribute to Biosite's continued success and market
leadership."
Dr. Paradis has 20 years of clinical, research and administrative
experience in emergency medicine. Most recently, he was professor of surgery
and medicine at the University of Colorado, and senior medical director of
emergency medicine at University of Colorado Hospital, where he headed a
research group with active programs in real-time diagnostic technology,
hemodynamics, hypothermia, stroke biomarkers, fibrinolytics and emergency
cardiopulmonary bypass.
Active in organized medicine, Dr. Paradis has been a member of numerous
medical professional organizations, including the Society for Academic
Emergency Medicine (SAEM), Society of Critical Care Medicine (SCCM), the
American College of Emergency Medicine (ACEP), and the American Academy of
Emergency Medicine (AAEM) among others. Dr. Paradis was one of the founding
members of SAEM's Reperfusion Working Group, and has been active in the
American Heart Association (AHA), serving on the Advanced Cardiac Life Support
(ACLS) Subcommittee for more than 10 years. He is a fellow of the American
Board of Emergency Medicine.
Dr. Paradis is on the editorial boards of The American Journal of
Emergency Medicine, Resuscitation, and the Critical Illness section of the
Journal of the American Medical Association (JAMA). He has published more
than 60 scientific articles and texts.
Walton joined Biosite in 1997 as the director of program management and
was promoted to senior director in 2004. She created the Company's project
management office, successfully leading multi-disciplinary teams through
processes leading to new product commercialization and ongoing product
improvement. Walton's expertise contributed to the expansion of Biosite's
product offerings, which consisted of a single drug screening product, the
Triage Drugs of Abuse Panel, in 1997 and today include more than 10 products
addressing a variety of acute diseases and conditions.
Prior to joining Biosite, Walton held the positions of vice president of
quality assurance/compliance/project management and vice president operations
for Nichols Institute Diagnostics (a division of Corning Nichols & Quest
Diagnostics), a biotechnology company that develops, manufactures and markets
medical diagnostic tests and instrumentation. Prior to that, she obtained
clinical and medical technology experience at SmithKline Clinical Laboratory.
Walton is a Certified Regulatory Affairs Professional, a Certified Quality
Manager and a Certified Project Management Professional. She holds a
bachelor's degree in biology with an emphasis on medical technology from
California State University of Hayward.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in over 50 international markets. Information on Biosite
can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, VP, Corporate & Investor
Relations of Biosite Incorporated, +1-858-455-4808, ext. 3187,
npadilla@biosite.com
|
